PCMT1 and invasive breast carcinoma: Based on the TCGA database, the survival curves of PCMT1 in breast invasive carcinoma (BRCA) also indicated that the low PCMT1 expression group had a better prognosis than the high expression group (Fig. 1C), consistent with the previous result.